Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FKA08
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $21,254
Award facts
- Contract value 100% obligated
- $21,253.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $21,253.68 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dupixent 300 mg/2 ml pen auto-injectors with a completion date of September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The award leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement supporting military and veteran healthcare systems. Dupixent (dupilumab) is a specialty biologic medication commonly used to treat moderate-to-severe atopic dermatitis, eosinophilic asthma, and other inflammatory conditions. The delivery order represents a continuation of AmerisourceBergen's substantial role in supplying specialized pharmaceutical products through the DLA's pharmaceutical supply chain, reinforcing the company's position as a key provider of brand-name and generic medications, vaccines, and medical devices across multiple therapeutic domains to support Department of Defense healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FKA08?
SPE2DB25FKA08 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 19, 2025.
How much is contract SPE2DB25FKA08 worth?
The government has obligated $21,254 on SPE2DB25FKA08.
Is contract SPE2DB25FKA08 an order under another contract?
Yes. SPE2DB25FKA08 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FKA08 competed?
The extent of competition for SPE2DB25FKA08 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award